169 related articles for article (PubMed ID: 16091005)
1. Effect of resveratrol on angiogenesis and platelet/fibrin-accelerated tumor growth in the chick chorioallantoic membrane model.
Mousa SS; Mousa SS; Mousa SA
Nutr Cancer; 2005; 52(1):59-65. PubMed ID: 16091005
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenesis efficacy of the garlic ingredient alliin and antioxidants: role of nitric oxide and p53.
Mousa AS; Mousa SA
Nutr Cancer; 2005; 53(1):104-10. PubMed ID: 16351512
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.
Kimura Y; Sumiyoshi M; Baba K
Cancer Sci; 2008 Oct; 99(10):2083-96. PubMed ID: 19016770
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy.
Mousa SA; Mohamed S
Oncol Rep; 2004 Oct; 12(4):683-8. PubMed ID: 15375485
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenesis and anticancer efficacy of TA138, a novel alphavbeta3 antagonist.
Mousa SA; Mohamed S; Wexler EJ; Kerr JS
Anticancer Res; 2005; 25(1A):197-206. PubMed ID: 15816539
[TBL] [Abstract][Full Text] [Related]
6. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
7. Grape seed proanthocyanidins inhibit colon cancer-induced angiogenesis through suppressing the expression of VEGF and Ang1.
Huang S; Yang N; Liu Y; Gao J; Huang T; Hu L; Zhao J; Li Y; Li C; Zhang X
Int J Mol Med; 2012 Dec; 30(6):1410-6. PubMed ID: 23026853
[TBL] [Abstract][Full Text] [Related]
8. γ-Tocotrienol inhibits angiogenesis of human umbilical vein endothelial cell induced by cancer cell.
Li Y; Sun WG; Liu HK; Qi GY; Wang Q; Sun XR; Chen BQ; Liu JR
J Nutr Biochem; 2011 Dec; 22(12):1127-36. PubMed ID: 21292465
[TBL] [Abstract][Full Text] [Related]
9. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes.
Bråkenhielm E; Cao R; Cao Y
FASEB J; 2001 Aug; 15(10):1798-800. PubMed ID: 11481234
[No Abstract] [Full Text] [Related]
10. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
Gao W; Jin K; Lan H; Han N; Cao F; Teng L
Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells.
Larsson H; Sjöblom T; Dixelius J; Ostman A; Ylinenjärvi K; Björk I; Claesson-Welsh L
Cancer Res; 2000 Dec; 60(23):6723-9. PubMed ID: 11118058
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of angiogenesis by a novel small peptide consisting of the active fragments of platelet factor-4 and vasostatin.
Li X; Jiang L; Wang Y; Xiao Y; Huang Y; Yao Q; Yang Y; Wu X
Cancer Lett; 2007 Oct; 256(1):29-32. PubMed ID: 17574330
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic activity of the purine analog 6-thioguanine.
Presta M; Belleri M; Vacca A; Ribatti D
Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690
[TBL] [Abstract][Full Text] [Related]
14. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir.
Liekens S; Neyts J; De Clercq E; Verbeken E; Ribatti D; Presta M
Cancer Res; 2001 Jul; 61(13):5057-64. PubMed ID: 11431341
[TBL] [Abstract][Full Text] [Related]
16. [Anti-angiogenetic effect of arenobufagin in vitro and in vivo].
Liu JS; Zhang DM; Chen MF; Li MM; Luo QD; Kurihara H; Ye WC
Yao Xue Xue Bao; 2011 May; 46(5):527-33. PubMed ID: 21800539
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
[TBL] [Abstract][Full Text] [Related]
18. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface.
Davis FB; Mousa SA; O'Connor L; Mohamed S; Lin HY; Cao HJ; Davis PJ
Circ Res; 2004 Jun; 94(11):1500-6. PubMed ID: 15117822
[TBL] [Abstract][Full Text] [Related]
19. Ta1722, an anti-angiogenesis inhibitor targeted on VEGFR-2 against human hepatoma.
Zheng L; He X; Ma W; Dai B; Zhan Y; Zhang Y
Biomed Pharmacother; 2012 Oct; 66(7):499-505. PubMed ID: 22854322
[TBL] [Abstract][Full Text] [Related]
20. Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway.
Dong Y; Lu B; Zhang X; Zhang J; Lai L; Li D; Wu Y; Song Y; Luo J; Pang X; Yi Z; Liu M
Carcinogenesis; 2010 Dec; 31(12):2097-104. PubMed ID: 20732905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]